Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report

References

1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75–84.10.1016/S0140-6736(08)60074-4Search in Google Scholar

2. Reichman DE, Laufer MR. Congenital uterine anomalies affecting reproduction. Best Pract Res Clin Obstet Gynaecol 2010;24:193–208.10.1016/j.bpobgyn.2009.09.006Search in Google Scholar

3. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001;7:161–74.10.1093/humupd/7.2.161Search in Google Scholar

4. Zhang Y, Zhao YY, Qiao J. Obstetric outcome of women with uterine anomalies in China. Chin Med J(Engl) 2010;123: 418–22.Search in Google Scholar

5. Heinonen PK. Clinical implications of the didelphic uterus: long-term follow-up of 49 cases. Eur J Obstet Gynecol Reprod Biol 2000;91:183–90.10.1016/S0301-2115(99)00259-6Search in Google Scholar

6. Suhail M, Khan H, Suhail S. Uterus didelphys having single pregnancy in her right horn: a case report. J Chin Med Assoc 2010;5:46–49.Search in Google Scholar

7. Maki Y, Furukawa S, Sameshima H, Ikenoue T. Independent uterine contractions in simultaneous twin pregnancy in each horn of the uterus didelphys. J Obstet Gynaecol 2014;40:836–9.10.1111/jog.12219Search in Google Scholar PubMed

8. Chan YY, Jayaprakasan K, Tan A, Thomton JG, Coomarasamy A, Raine-Fenning NJ. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound OBstet Gynecol 2011;38:371–82.10.1002/uog.10056Search in Google Scholar PubMed

9. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O’Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379–85.10.1056/NEJMoa035140Search in Google Scholar PubMed

10. Chawanpaiboon S, Pimoi K, Sirisomboon R. Comparison of success rate of nifedipine, progesterone, and bed rest for inhibiting uterine contraction in threatened preterm labor. J OBstet Gynaecol Res 2011;37:787–91.10.1111/j.1447-0756.2010.01434.xSearch in Google Scholar PubMed

11. Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev 2013;7:CD004947.10.1002/14651858.CD004947.pub2Search in Google Scholar PubMed

12. Berghella V, Figueroa D, Szychowski JM, Owen J, Hankins GD, Iams JD, Sheffeld JS, Perez-Delboy A, Wing DA, Guzman ER. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet Gynecol 2010;202:351.e1–6.10.1016/j.ajog.2010.02.019Search in Google Scholar PubMed PubMed Central